Perrigo to Buy Elan for $8.6B to Get Irish Tax Base

July 29 (Bloomberg) -- Perrigo, a U.S. maker of over-the-counter medicines, agreed to buy Irish drug company Elan for $8.6 billion, gaining a low-tax base for international expansion. Olivia Sterns reports on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Soylent: The Food of the Future?
52:51 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Full Show: What'd You Miss? (07/22)
  • Should More Filmmakers Use Virtual Reality Technology?
  • How Important Is the Smartwatch Market to Apple?